These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 8512568)

  • 1. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis.
    Santelli G; Califano D; Chiappetta G; Vento MT; Bartoli PC; Zullo F; Trapasso F; Viglietto G; Fusco A
    Am J Pathol; 1999 Sep; 155(3):799-804. PubMed ID: 10487837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of thymosin beta 4 in a variety of diseases.
    Ye C; Dai Q; Deng L; Huang H
    Asian J Surg; 2024 Jun; ():. PubMed ID: 38824027
    [No Abstract]   [Full Text] [Related]  

  • 3. Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.
    Burnell SEA; Capitani L; MacLachlan BJ; Mason GH; Gallimore AM; Godkin A
    Immunother Adv; 2022; 2(1):ltab025. PubMed ID: 35265944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Di-(2-ethylhexyl) phthalate-induced tumor growth is regulated by primary cilium formation via the axis of H
    Lee JW; Thuy PX; Han HK; Moon EY
    Int J Med Sci; 2021; 18(5):1247-1258. PubMed ID: 33526986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A loss of profilin-1 in late-stage oral squamous cell carcinoma.
    Adami GR; O'Callaghan TN; Kolokythas A; Cabay RJ; Zhou Y; Schwartz JL
    J Oral Pathol Med; 2017 Aug; 46(7):489-495. PubMed ID: 27862305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin ß4 expression in colorectal polyps and adenomas.
    Nemolato S; Cabras T; Restivo A; Zorcolo L; Di Felice E; Fanni D; Gerosa C; Messana I; Castagnola M; Faa G; Casula G
    Clinics (Sao Paulo); 2013 Sep; 68(9):1220-4. PubMed ID: 24141838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
    Tilghman SL; Townley I; Zhong Q; Carriere PP; Zou J; Llopis SD; Preyan LC; Williams CC; Skripnikova E; Bratton MR; Zhang Q; Wang G
    Mol Cell Proteomics; 2013 Sep; 12(9):2440-55. PubMed ID: 23704778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.
    Kim NS; Kang YJ; Jo JO; Kim HY; Oh YR; Kim YO; Jung MH; Ock MS; Cha HJ
    Pathol Oncol Res; 2011 Sep; 17(3):493-502. PubMed ID: 21213129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.
    Rossdeutsch A; Smart N; Riley PR
    J Mol Med (Berl); 2008 Jan; 86(1):29-35. PubMed ID: 17701149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility.
    Maelan AE; Rasmussen TK; Larsson LI
    Histochem Cell Biol; 2007 Jan; 127(1):109-13. PubMed ID: 16786322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of thymosins in cancers and other organ systems.
    Chen C; Li M; Yang H; Chai H; Fisher W; Yao Q
    World J Surg; 2005 Mar; 29(3):264-70. PubMed ID: 15706436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS; Ino Y; Sakamoto M; Hirohashi S
    Jpn J Cancer Res; 2002 Sep; 93(9):1020-8. PubMed ID: 12359056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells.
    Kobayashi T; Okada F; Fujii N; Tomita N; Ito S; Tazawa H; Aoyama T; Choi SK; Shibata T; Fujita H; Hosokawa M
    Am J Pathol; 2002 Mar; 160(3):869-82. PubMed ID: 11891186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines.
    Nakamura N; Takenaga K
    Clin Exp Metastasis; 1998 Jul; 16(5):471-9. PubMed ID: 10091942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas.
    Yamamoto T; Gotoh M; Kitajima M; Hirohashi S
    Biochem Biophys Res Commun; 1993 Jun; 193(2):706-10. PubMed ID: 8512568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.
    Giavazzi R; Campbell DE; Jessup JM; Cleary K; Fidler IJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1928-33. PubMed ID: 3948174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma.
    Weterman MA; van Muijen GN; Ruiter DJ; Bloemers HP
    Int J Cancer; 1993 Jan; 53(2):278-84. PubMed ID: 8425765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer.
    Yamamoto H; Itoh F; Hinoda Y; Imai K
    Cancer Res; 1996 Aug; 56(15):3605-9. PubMed ID: 8758933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.